Matches in Wikidata for { <http://www.wikidata.org/entity/Q77319412> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q77319412 description "artículu científicu espublizáu en setiembre de 1998" @default.
- Q77319412 description "scientific article published on 01 September 1998" @default.
- Q77319412 description "wetenschappelijk artikel" @default.
- Q77319412 description "наукова стаття, опублікована у вересні 1998" @default.
- Q77319412 name "Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block" @default.
- Q77319412 name "Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block" @default.
- Q77319412 type Item @default.
- Q77319412 label "Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block" @default.
- Q77319412 label "Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block" @default.
- Q77319412 prefLabel "Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block" @default.
- Q77319412 prefLabel "Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block" @default.
- Q77319412 P1433 Q77319412-E7185C96-77A6-4ED7-962C-2567D66A593E @default.
- Q77319412 P1476 Q77319412-A68885F9-94F6-4A53-A6D1-7AE6C06DB44D @default.
- Q77319412 P2093 Q77319412-1BEBA798-B60F-4243-BB17-9371600E60E7 @default.
- Q77319412 P2093 Q77319412-86168EFC-3489-4E29-B29C-1312EFE15233 @default.
- Q77319412 P2093 Q77319412-8A6E54E8-7BFB-4A73-8993-66E2B5E1AA05 @default.
- Q77319412 P2093 Q77319412-D1CFA800-AF0F-4B5E-B0D0-E6B62E9CE921 @default.
- Q77319412 P2093 Q77319412-E5711CFC-E54F-4353-A3F0-C62B63B9409C @default.
- Q77319412 P304 Q77319412-6D33E0CA-E3FD-4FE0-BA14-FB3DAC79572B @default.
- Q77319412 P31 Q77319412-6A4FCCE2-D474-4927-A4F6-6730D0EF0EB0 @default.
- Q77319412 P356 Q77319412-E05086A2-8C78-41E3-B794-D0CAD0145E29 @default.
- Q77319412 P407 Q77319412-CBB20069-B08F-44FE-AE36-1A25FB02314B @default.
- Q77319412 P433 Q77319412-D7556121-578B-415F-B9ED-9E0EC86E6FE0 @default.
- Q77319412 P478 Q77319412-6CE75A12-CB3F-4E4A-8966-01DBFEE0F4BE @default.
- Q77319412 P577 Q77319412-270E4887-B5F8-4096-A0BF-A2F8C9406009 @default.
- Q77319412 P698 Q77319412-60DE24E2-19D7-476E-8BA9-79F9A6A07911 @default.
- Q77319412 P921 Q77319412-8D8B03AF-4AE4-4ABD-9BC7-C4E727A115D0 @default.
- Q77319412 P921 Q77319412-BEC756C8-4FA5-427F-9CBD-239C872DC8AB @default.
- Q77319412 P356 00000542-199809000-00022 @default.
- Q77319412 P698 9743409 @default.
- Q77319412 P1433 Q2012635 @default.
- Q77319412 P1476 "Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block" @default.
- Q77319412 P2093 "J H Proost" @default.
- Q77319412 P2093 "J M Wierda" @default.
- Q77319412 P2093 "M C Houwertjes" @default.
- Q77319412 P2093 "T M Beaufort" @default.
- Q77319412 P2093 "V Nigrovic" @default.
- Q77319412 P304 "707-714" @default.
- Q77319412 P31 Q13442814 @default.
- Q77319412 P356 "10.1097/00000542-199809000-00022" @default.
- Q77319412 P407 Q1860 @default.
- Q77319412 P433 "3" @default.
- Q77319412 P478 "89" @default.
- Q77319412 P577 "1998-09-01T00:00:00Z" @default.
- Q77319412 P698 "9743409" @default.
- Q77319412 P921 Q413877 @default.
- Q77319412 P921 Q424378 @default.